M
Mona Kumar
Monisha ("Mona") Kumar, MD, is a neurointensivist and Professor of Neurology at the University of Pennsylvania, where she is Vice Chair of Quality and Safety for Neurology and Director of the Neuro ICU.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
Sep 30, 2026
HOT TOPICS: Updated ICH Antithrombotic Reversal Guideline
3:22

Eric LawsonHOST
Can you all discuss some of the differences in the methodology employed? Maybe touch on some of those five main questions you use to guide the review and what makes this study group a little more unique?
M
3:38Mona KumarGUEST
The methodological shift between the 2016 guideline and the 2026 guidelines is actually pretty substantial.
M
3:45Mona KumarGUEST
There were differences in evidence rating, risk of bias assessments, decision framework, panel structure, as you alluded to, and literature search.
M
3:54Mona KumarGUEST
The 2016 guidelines did apply grade methodology, but back then there were no pooled meta-analyses.
M
4:01Mona KumarGUEST
The case series threshold was greater than five patients, and that's just because there was a paucity of data at the time.